Literature DB >> 32607819

Human microbiome and prostate cancer development: current insights into the prevention and treatment.

Solmaz Ohadian Moghadam1, Seyed Ali Momeni2.   

Abstract

The huge communities of microorganisms that symbiotically colonize humans are recognized as significant players in health and disease. The human microbiome may influence prostate cancer development. To date, several studies have focused on the effect of prostate infections as well as the composition of the human microbiome in relation to prostate cancer risk. Current studies suggest that the microbiota of men with prostate cancer significantly differs from that of healthy men, demonstrating that certain bacteria could be associated with cancer development as well as altered responses to treatment. In healthy individuals, the microbiome plays a crucial role in the maintenance of homeostasis of body metabolism. Dysbiosis may contribute to the emergence of health problems, including malignancy through affecting systemic immune responses and creating systemic inflammation, and changing serum hormone levels. In this review, we discuss recent data about how the microbes colonizing different parts of the human body including urinary tract, gastrointestinal tract, oral cavity, and skin might affect the risk of developing prostate cancer. Furthermore, we discuss strategies to target the microbiome for risk assessment, prevention, and treatment of prostate cancer.

Entities:  

Keywords:  biomarker; microbiome; molecular pathological epidemiology (MPE); prevention; prostate cancer; treatment

Mesh:

Year:  2020        PMID: 32607819     DOI: 10.1007/s11684-019-0731-7

Source DB:  PubMed          Journal:  Front Med        ISSN: 2095-0217            Impact factor:   4.592


  245 in total

1.  International variation in prostate cancer incidence and mortality rates.

Authors:  Melissa M Center; Ahmedin Jemal; Joannie Lortet-Tieulent; Elizabeth Ward; Jacques Ferlay; Otis Brawley; Freddie Bray
Journal:  Eur Urol       Date:  2012-03-08       Impact factor: 20.096

2.  Cancer statistics, 2018.

Authors:  Rebecca L Siegel; Kimberly D Miller; Ahmedin Jemal
Journal:  CA Cancer J Clin       Date:  2018-01-04       Impact factor: 508.702

3.  The human microbiome project.

Authors:  Peter J Turnbaugh; Ruth E Ley; Micah Hamady; Claire M Fraser-Liggett; Rob Knight; Jeffrey I Gordon
Journal:  Nature       Date:  2007-10-18       Impact factor: 49.962

4.  Estimation of the projections of the incidence rates, mortality and prevalence due to common cancer site in Isfahan, Iran.

Authors:  Farhad Moradpour; Zeinab Fatemi
Journal:  Asian Pac J Cancer Prev       Date:  2013

5.  Helicobacter pylori infection and the development of gastric cancer.

Authors:  N Uemura; S Okamoto; S Yamamoto; N Matsumura; S Yamaguchi; M Yamakido; K Taniyama; N Sasaki; R J Schlemper
Journal:  N Engl J Med       Date:  2001-09-13       Impact factor: 91.245

6.  Infections and inflammation in prostate cancer.

Authors:  Karen S Sfanos; William B Isaacs; Angelo M De Marzo
Journal:  Am J Clin Exp Urol       Date:  2013-12-25

Review 7.  The role of the gastrointestinal microbiome in Helicobacter pylori pathogenesis.

Authors:  Alexander Sheh; James G Fox
Journal:  Gut Microbes       Date:  2013-08-19

Review 8.  Prostate cancer progression and mortality: a review of diet and lifestyle factors.

Authors:  Sam F Peisch; Erin L Van Blarigan; June M Chan; Meir J Stampfer; Stacey A Kenfield
Journal:  World J Urol       Date:  2016-08-12       Impact factor: 4.226

Review 9.  Epidemiology of prostate cancer in Asian countries.

Authors:  Takahiro Kimura; Shin Egawa
Journal:  Int J Urol       Date:  2018-05-08       Impact factor: 3.369

10.  Prostate-Specific Antigen Density and Gleason Score Predict Adverse Pathologic Features in Patients with Clinically Localized Prostate Cancer.

Authors:  Mohammad Reza Nowroozi; Seyed Ali Momeni; Solmaz Ohadian Moghadam; Elnaz Ayati; Afshin Mortazavi; Simin Arfae; Hassan Jamshidian; Mohsen Taherimahmoudi; Mohsen Ayati
Journal:  Nephrourol Mon       Date:  2016-08-15
View more
  5 in total

1.  Bacterial Lipopolysaccharide Augmented Malignant Transformation and Promoted the Stemness in Prostate Cancer Epithelial Cells.

Authors:  Sijie Tang; Xueqi Lian; Huiying Cheng; Jiaqian Guo; Daguang Ni; Can Huang; Xiang Gu; Hong Meng; Jiajia Jiang; Xiaohua Li
Journal:  J Inflamm Res       Date:  2021-11-09

Review 2.  Novel directions of precision oncology: circulating microbial DNA emerging in cancer-microbiome areas.

Authors:  Liting You; Juan Zhou; Zhaodan Xin; J Spencer Hauck; Feifei Na; Jie Tang; Xiaohan Zhou; Zichen Lei; Binwu Ying
Journal:  Precis Clin Med       Date:  2022-02-03

3.  Gut Microflora Modulates Th17/Treg Cell Differentiation in Experimental Autoimmune Prostatitis via the Short-Chain Fatty Acid Propionate.

Authors:  He-Xi Du; Shao-Yu Yue; Di Niu; Chang Liu; Li-Gang Zhang; Jing Chen; Yang Chen; Yu Guan; Xiao-Liang Hua; Chun Li; Xian-Guo Chen; Li Zhang; Chao-Zhao Liang
Journal:  Front Immunol       Date:  2022-07-04       Impact factor: 8.786

Review 4.  Prostate Infiltration by Treg and Th17 Cells as an Immune Response to Propionibacterium acnes Infection in the Course of Benign Prostatic Hyperplasia and Prostate Cancer.

Authors:  Sebastian Radej; Monika Szewc; Ryszard Maciejewski
Journal:  Int J Mol Sci       Date:  2022-08-09       Impact factor: 6.208

Review 5.  The Oral Microbiome and Cancer.

Authors:  Muhammad Irfan; Renata Zoraida Rizental Delgado; Jorge Frias-Lopez
Journal:  Front Immunol       Date:  2020-10-23       Impact factor: 7.561

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.